Renaissance Technologies »

Inhibikase Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 17k 1.68
2024-09-30 $26k 20k 1.30
2024-06-30 $25k 21k 1.21
2024-03-31 $46k 21k 2.15
2023-12-31 $31k 24k 1.27
2023-09-30 $22k 16k 1.36
2023-06-30 $46k 13k 3.62